Subcutaneous injection, in courses
Epitalon
A compound studied for sleep and healthy aging.
Epitalon is a synthetic compound studied for potential effects on the pineal gland and sleep regulation. It has not been through the clinical trials the FDA requires to approve a drug. rhome's Epitalon is compounded by a licensed pharmacy from your clinician's prescription and dispensed in separate courses, not as a standing monthly refill.
From $139 per course1not FDA approved
Compounded under a temporary federal policy (HHS, October 28, 2026) while the FDA decides whether to add it to its compounding list. That is not FDA approval, and the policy can change.
Your rhythm
On the schedule your clinician sets.
What to expect
Living with Epitalon.
- 01
Prescribed in short, defined courses
- 02
Compounded by licensed U.S. pharmacies
- 03
Clinician review before each course
- 04
Message your care team any time
Questions
Straight answers.
No. On October 28, 2026, the U.S. Department of Health and Human Services issued an interim enforcement-discretion policy: it does not intend to act against licensed pharmacies that compound this substance from a patient-specific prescription, under set conditions, while the FDA finishes its rulemaking. That is not FDA approval. The substance has not been evaluated by the FDA for safety, effectiveness, or quality the way an approved drug is, and it has not been added to the FDA's 503A bulk drug list; an FDA advisory committee recommended adding it in July 2026 and the FDA has not decided. The policy is temporary and can change.
The federal interim policy covers Epitalon dispensed in intermittent courses, so that is how rhome offers it. Your clinician decides whether and when another course is appropriate.
Then a box at the door.
Your first box, in your treatment’s colour, with a card on top with your name on it.